health catalyst is dedicated to enabling health care organizations to fundamentally improve care by building the most comprehensive and fully integrated suite of healthcare data warehousing and process improvement solutions available. health catalyst was formed by a group of healthcare veterans with vast data warehousing and quality improvement experience. our founders and executives collaborated for nearly a decade to revolutionize clinical process models using analytics. during development, they faced numerous hurdles in the quest to develop a data warehouse that could handle the complexities unique to healthcare data. after determining that the predominant approaches to data modeling weren’t effective for healthcare data, they discovered the solution, which is now known as the adaptive data architecture. using a late-binding bus architecture, catalyst’s adaptive data model is agile, flexible, and can be implemented in a matter of weeks compared to the months or years traditional app
Company profile
Ticker
HCAT
Exchange
Website
CEO
Daniel D. Burton
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
HQC Holdings, Inc.
SEC CIK
Corporate docs
Subsidiaries
Health Catalyst Australia PTY LTD • Health Catalyst UK Ltd • Health Catalyst India Private Limited • Health Catalyst Singapore Pte. Ltd. • Able Health, LLC • ARMUS I LLC • Electronic Registry Systems, LLC • Healthfinch, LLC • KPI Ninja, LLC • Medicity LLC ...
IRS number
453337483
HCAT stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
22 Feb 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Health Catalyst Reports Fourth Quarter and Year End 2023 Results
22 Feb 24
8-K
Other Events
8 Jan 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
Health Catalyst Reports Third Quarter 2023 Results
2 Nov 23
8-K
Health Catalyst Reports Third Quarter 2023 Preliminary Results
27 Oct 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
Health Catalyst Reports Second Quarter 2023 Results
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
Transcripts
HCAT
Earnings call transcript
2023 Q4
22 Feb 24
HCAT
Earnings call transcript
2023 Q3
2 Nov 23
HCAT
Earnings call transcript
2023 Q2
8 Aug 23
HCAT
Earnings call transcript
2023 Q1
9 May 23
HCAT
Earnings call transcript
2022 Q4
28 Feb 23
HCAT
Earnings call transcript
2022 Q3
8 Nov 22
HCAT
Earnings call transcript
2022 Q2
7 Aug 22
HCAT
Earnings call transcript
2022 Q1
11 May 22
HCAT
Earnings call transcript
2021 Q4
2 Mar 22
HCAT
Earnings call transcript
2021 Q3
10 Nov 21
Latest ownership filings
4
Linda Llewelyn
17 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
4
Linda Llewelyn
19 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
4
Daniel LeSueur
5 Mar 24
4
Jason Alger
5 Mar 24
4
Benjamin Landry
5 Mar 24
4
Bryan Truman Hunt
5 Mar 24
4
Kevin Lee Freeman
5 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 94.97 mm | 94.97 mm | 94.97 mm | 94.97 mm | 94.97 mm | 94.97 mm |
Cash burn (monthly) | 6.91 mm | 2.44 mm | 8.19 mm | 10.90 mm | (no burn) | 2.41 mm |
Cash used (since last report) | 46.86 mm | 16.54 mm | 55.59 mm | 73.99 mm | n/a | 16.32 mm |
Cash remaining | 48.12 mm | 78.43 mm | 39.38 mm | 20.98 mm | n/a | 78.65 mm |
Runway (months of cash) | 7.0 | 32.2 | 4.8 | 1.9 | n/a | 32.7 |
Institutional ownership, Q3 2023
83.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 156 |
Opened positions | 18 |
Closed positions | 14 |
Increased positions | 55 |
Reduced positions | 51 |
13F shares | Current |
---|---|
Total value | 486.28 bn |
Total shares | 48.63 mm |
Total puts | 17.20 k |
Total calls | 20.60 k |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 6.44 mm | $65.19 bn |
BLK Blackrock | 4.94 mm | $50.02 bn |
Point72 Asset Management | 3.88 mm | $39.30 bn |
Wellington Management | 3.00 mm | $30.37 bn |
First Light Asset Management | 2.93 mm | $29.65 bn |
JPM JPMorgan Chase & Co. | 1.98 mm | $20.03 bn |
Daventry | 1.57 mm | $15.93 bn |
Dimensional Fund Advisors | 1.48 mm | $14.98 bn |
STT State Street | 1.46 mm | $14.78 bn |
Geode Capital Management | 1.18 mm | $11.95 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | Linda Llewelyn | Common Stock | Sell | Dispose S | No | Yes | 6.11 | 2,005 | 12.25 k | 126,226 |
15 Mar 24 | Linda Llewelyn | Common Stock | Sell | Dispose S | No | Yes | 7.8043 | 2,005 | 15.65 k | 128,231 |
1 Mar 24 | LeSueur Daniel | Common Stock | Grant | Acquire A | No | No | 0 | 70,000 | 0.00 | 174,219 |
1 Mar 24 | LeSueur Daniel | Common Stock | Payment of exercise | Dispose F | No | No | 8.0512 | 3,279 | 26.40 k | 104,219 |
1 Mar 24 | Jason Alger | Common Stock | Grant | Acquire A | No | No | 0 | 70,000 | 0.00 | 122,231 |
1 Mar 24 | Jason Alger | Common Stock | Payment of exercise | Dispose F | No | No | 8.0512 | 2,474 | 19.92 k | 52,231 |
1 Mar 24 | Benjamin Landry | Common Stock | Payment of exercise | Dispose F | No | No | 8.0512 | 3,315 | 26.69 k | 120,889 |
News
What 7 Analyst Ratings Have To Say About Health Catalyst
10 Apr 24
Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price Target
10 Apr 24
SMART Global Reports Q2 Results, Joins Health Catalyst And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
10 Apr 24
Keybanc Downgrades Health Catalyst to Sector Weight
10 Apr 24
Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price Target
5 Mar 24
Press releases
Health Catalyst to Participate in Upcoming Investor Conferences
4 Mar 24
Health Catalyst Names UnityPoint Health Winner of the 2024 Flywheel Award
27 Feb 24
The 2024 Healthcare Analytics Summit (HAS) Kicks Off Today
27 Feb 24
Health Catalyst Reports Fourth Quarter and Year End 2023 Results
22 Feb 24
Health Catalyst's Able Health Registry Receives CMS's QPP Qualified Registry Approval for 2024
21 Feb 24